Influence of myeloperoxidase by anti-myeloperoxidase antibodies and its association with the disease activity in microscopic polyangiitis

Rheumatology

Volumn 49, Issue 11, 2010, Pages 2068-2075

  Xu, Peng Cheng ^a,b   Chen, Min ^a,b   Cui, Zhao ^a,b   Zhao, Ming Hui ^a,b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Anti neutrophil cytoplasmic antibodies; Microscopic polyangiitis; Myeloperoxidase; Oxidation activity

Indexed keywords

AUTOANTIBODY; CERULOPLASMIN; ENZYME ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; MYELOPEROXIDASE; MYELOPEROXIDASE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AFFINITY CHROMATOGRAPHY; AGED; ANTIBODY AFFINITY; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MICROSCOPIC POLYANGIITIS; OXIDATION; PRIORITY JOURNAL; PROTEIN PURIFICATION;

ADOLESCENT; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODY AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; PEROXIDASE; YOUNG ADULT;

EID: 78649381973     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq203     Document Type: Article

References (26)

1. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997;337:1512-23.
2. Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, Wang HY. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int 2005;68:2225-9.
3. Chen M, Yu F, Wang SX, Zou WZ, Zhang Y, Zhao MH. Renal histology in Chinese Patients with anti-myeloperoxidase autoantibodies positive Wegener's granulomatosis. Nephrol Dial Transplant 2007; 22:139-45.
4. Bansal PJ, Tobin MC. Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidaseantineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 2004;93:398-401.
5. Xiao H, Heeringa P, Hu P et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002; 110:955-63.
6. Kettritz R, Jennette JC, Falk RJ. Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol 1997;8:386-94.
7. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-9.
8. Foote CS, Goyne TE, Lehrer RI. Assessment of chlorination by human neutrophils. Nature 1983;301: 715-6.
9. Guilpain P, Servettaz A, Goulvestre C et al. Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis. Arthritis Rheum 2007;56: 2455-63.
10. Griffin SV, Chapman PT, Lianos EA, Lockwood CM. The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies. Kidney Int 1999;55:917-25.
11. Zhang AH, Chen M, Gao Y, Zhao MH, Wang HY. Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis. Clin Immunol 2007;122: 187-93.
12. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
13. Jayne DR, Rasmussen N. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Mayo Clin Proc 1997;72:737-47.
14. Zhao MH, Lockwood CM. A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability -increasing protein from human neutrophil granule acid extract. J Immunol Methods 1996;197:121-30.
15. Hassan NF, Campbell DE, Douglas SD. O-phenylenediamine oxidation by phorbol myristate acetate-stimulated human polymorphonuclear leukocytes: characterization of two distinct oxidative mechanisms. Clin Immunol Immunopathol 1987;42:274-80.
16. Nolle B, Specks U, Ludemann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989;111:28-40.
17. Kokolina E, Noel LH, Nusbaum P et al. Isotype and affinity of anti-myeloperoxidase autoatibodies in systemic vasculitis. Kidney Int 1994;46:177-84.
18. Gao Y, Ye H, Yu F, Guo XH, Zhao MH. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis. Clin Immunol 2005;117:87-93.
19. Lin W, Chen M, Zhao MH. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis. Autoimmunity 2009; 42:198-202.
20. Brouwer E, Tervaert JW, Horst G et al. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 1991;83:379-86.
21. Segelmark M, Wieslander J. IgG subclasses of antineutrophil cytoplasmic antibodies (ANCA). Nephrol Dial Transplant 1993;8:696-702.
22. Esnault VL, Jayne DR, Weetman AP, Lockwood CM. IgG subclass distribution and relative functional affinity of anti-myeloperoxidase antibodies in systemic vasculitis at presentation and during follow-up. Immunology 1991;74: 714-8.
23. Roux KH, Strelets L, Michaelsen TE. Flexibility of IgG subclasses. J Immunol 1997;159:3372-82.
24. Erdbrügger U, Hellmark T, Bunch DO et al. Mapping of myeloperoxidase epitopes recognized by MPO-ANCA using human-mouse MPO chimers. Kidney Int 2006;69: 1799-805.
25. Suzuki K, Kobayashi S, Yamazaki K et al. Analysis of risk epitopes of anti-neutrophil antibody MPO-ANCA in vasculitis in Japanese population. Microbiol Immunol 2007;51:1215-20.
26. Daouk GH, Palsson R, Arnaout MA. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Kidney Int 1995;47:1528-36.